These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 14758432)

  • 81. The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries.
    Jadhav S; Datla M; Kreeftenberg H; Hendriks J
    Vaccine; 2008 Mar; 26(13):1611-5. PubMed ID: 18294742
    [TBL] [Abstract][Full Text] [Related]  

  • 82. New vaccines against otitis media: projected benefits and cost-effectiveness.
    O'Brien MA; Prosser LA; Paradise JL; Ray GT; Kulldorff M; Kurs-Lasky M; Hinrichsen VL; Mehta J; Colborn DK; Lieu TA
    Pediatrics; 2009 Jun; 123(6):1452-63. PubMed ID: 19482754
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Translational research to assist policy decisions about introducing new vaccines in developing countries.
    Clemens JD; Jodar L
    J Health Popul Nutr; 2004 Sep; 22(3):223-31. PubMed ID: 15609774
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Technologies that make administration of vaccines safer.
    Clements CJ; Larsen G; Jodar L
    Vaccine; 2004 May; 22(15-16):2054-8. PubMed ID: 15121322
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Health economic research on vaccinations and immunisation practices--an introductory primer.
    Szucs TD
    Vaccine; 2005 Mar; 23(17-18):2095-103. PubMed ID: 15755578
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Vaccinovigilance in Europe--need for timeliness, standardization and resources.
    Lankinen KS; Pastila S; Kilpi T; Nohynek H; Mäkelä PH; Olin P
    Bull World Health Organ; 2004 Nov; 82(11):828-35. PubMed ID: 15640918
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Parental vaccine safety concerns: results from the National Immunization Survey, 2001-2002.
    Allred NJ; Shaw KM; Santibanez TA; Rickert DL; Santoli JM
    Am J Prev Med; 2005 Feb; 28(2):221-4. PubMed ID: 15710279
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Provider response to different formats of the adult immunization schedule.
    Davis MM; Halasyamani LK; Sneller VP; Bishop KR; Clark SJ
    Am J Prev Med; 2005 Jul; 29(1):34-40. PubMed ID: 15958249
    [TBL] [Abstract][Full Text] [Related]  

  • 89. How do physicians immunize their own children? Differences among pediatricians and nonpediatricians.
    Posfay-Barbe KM; Heininger U; Aebi C; Desgrandchamps D; Vaudaux B; Siegrist CA
    Pediatrics; 2005 Nov; 116(5):e623-33. PubMed ID: 16263976
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Injection safety for immunisation--Andhra Pradesh experience.
    Kaipilyawar SB; Rao RG
    J Indian Med Assoc; 2005 Apr; 103(4):222-5. PubMed ID: 16173430
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Vaccines administered simultaneously: directions for new combination vaccines based on an historical review of the literature.
    Fletcher MA; Fabre P; Debois H; Saliou P
    Int J Infect Dis; 2004 Nov; 8(6):328-38. PubMed ID: 15494254
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?
    Lydon P; Levine R; Makinen M; Brenzel L; Mitchell V; Milstien JB; Kamara L; Landry S
    Vaccine; 2008 Dec; 26(51):6706-16. PubMed ID: 18952134
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Can a Compact Pre-Filled Auto-Disable Injection System (cPAD) Save Costs for DTP-HepB-Hib Vaccine as Compared with Single-Dose (SDV) and Multi-Dose Vials (MDV)? Evidence from Cambodia, Ghana, and Peru.
    Nogier C; Hanlon P; Wiedenmayer K; Maire N
    Drugs Real World Outcomes; 2015 Mar; 2(1):43-52. PubMed ID: 27747612
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Introducing hepatitis B virus vaccine into the Expanded Programme on Immunization in Bangladesh: a proposed method to evaluate whether the existing infrastructure has the capacity.
    Trama A; Walker D; Fox-Rushby J
    J Health Popul Nutr; 2005 Mar; 23(1):25-33. PubMed ID: 15884749
    [TBL] [Abstract][Full Text] [Related]  

  • 95. How effectively can health care settings beyond the traditional medical home provide vaccines to adolescents?
    Schaffer SJ; Fontanesi J; Rickert D; Grabenstein JD; Rothholz MC; Wang SA; Fishbein D;
    Pediatrics; 2008 Jan; 121 Suppl 1():S35-45. PubMed ID: 18174319
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Maternal and childhood immunization in developing countries: success, problems and new approaches].
    Guerin N
    Med Trop (Mars); 2003; 63(4-5):498-505. PubMed ID: 14763306
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The need for an evidence-based decision-making process with regard to control of hepatitis A.
    Gentile A
    J Viral Hepat; 2008 Oct; 15 Suppl 2():16-21. PubMed ID: 18837828
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Rapid assessment of injection practices in Mongolia.
    Logez S; Soyolgerel G; Fields R; Luby S; Hutin Y
    Am J Infect Control; 2004 Feb; 32(1):31-7. PubMed ID: 14755233
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Documentation of vaccine wastage in two different geographic contexts under the universal immunization program in India.
    Das MK; Sood M; Tambe MP; Sharma TD; Parande MAG; Surwade JB; Salunkhe NM; Patil SS; Pawar B; Guleri R; Kaushal C; Sindhu M
    BMC Public Health; 2020 Apr; 20(1):556. PubMed ID: 32334554
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Determining the optimal vaccine vial size in developing countries: a Monte Carlo simulation approach.
    Dhamodharan A; Proano RA
    Health Care Manag Sci; 2012 Sep; 15(3):188-96. PubMed ID: 22528136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.